These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11772282)

  • 1. Trimegestone: expanding therapeutic choices for the treatment of the menopause.
    Wahab M; Al-Azzawi F
    Expert Opin Investig Drugs; 2001 Sep; 10(9):1737-44. PubMed ID: 11772282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceptability and patterns of uterine bleeding in sequential trimegestone-based hormone replacement therapy: a dose-ranging study.
    Al-Azzawi F; Wahab M; Thompson J; Whitehead M; Thompson W
    Hum Reprod; 1999 Mar; 14(3):636-41. PubMed ID: 10221688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrial effects of three doses of trimegestone, a new orally active progestogen, on the postmenopausal endometrium.
    Ross D; Godfree V; Cooper A; Pryse-Davies J; Whitehead MI
    Maturitas; 1997 Sep; 28(1):83-8. PubMed ID: 9391999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of a change in the dose of trimegestone on the pattern of bleeding in estrogen-treated post-menopausal women: 6 month extension of a dose-ranging study.
    Wahab M; Thompson J; Whitehead M; Al-Azzawi F
    Hum Reprod; 2002 May; 17(5):1386-90. PubMed ID: 11980769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of submucous fibroids on the dose-dependent modulation of uterine bleeding by trimegestone in postmenopausal women treated with hormone replacement therapy.
    Wahab M; Thompson J; Al-Azzawi F
    BJOG; 2000 Mar; 107(3):329-34. PubMed ID: 10740328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The distribution of endometrial leukocytes and their proliferation markers in trimegestone-treated postmenopausal women compared to the endometrium of the natural cycle: a dose-ranging study.
    Wahab M; Thompson J; Al-Azzawi F
    Hum Reprod; 1999 May; 14(5):1201-6. PubMed ID: 10325261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceptability and patterns of endometrial bleeding in estradiol-based HRT regimens: a comparative study of cyclical sequential combinations of trimegestone or norethisterone acetate.
    al-Azzawi F; Wahab M; Thompson J; Pornel B; Hirvonen E; Ylikorkala O; van der Mooren MJ; Dillon J; Magaril C
    Climacteric; 2001 Dec; 4(4):343-54. PubMed ID: 11770191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 17 beta-estradiol and trimegestone alone, and in combination, on the bone and uterus of ovariectomized rats.
    Lepescheux L; Secchi J; Gaillard-Kelly M; Miller P
    Gynecol Endocrinol; 2001 Aug; 15(4):312-20. PubMed ID: 11560106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of different cyclical sequential progestins on endometrial vascularity in postmenopausal women compared with the natural cycle: a morphometric analysis.
    Wahab M; Thompson J; Al-Azzawi F
    Hum Reprod; 2000 Oct; 15(10):2075-81. PubMed ID: 11006176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacological profile of a novel norpregnance progestin (trimegestone).
    Philibert D; Bouchoux F; Degryse M; Lecaque D; Petit F; Gaillard M
    Gynecol Endocrinol; 1999 Oct; 13(5):316-26. PubMed ID: 10599548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial histomorphometry of trimegestone-based sequential hormone replacement therapy: a weighted comparison with the endometrium of the natural cycle.
    Wahab M; Thompson J; Hamid B; Deen S; Al-Azzawi F
    Hum Reprod; 1999 Oct; 14(10):2609-18. PubMed ID: 10527996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharma-Clinics. Medication of the month. Totelle Cycle: new sequential estrogen/progesterone regimen for hormone replacement therapy in menopause].
    Gaspard U
    Rev Med Liege; 2002 Jun; 57(6):408-12. PubMed ID: 12180037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience with trimegestone as a new progestin in HRT.
    Grubb G; Spielmann D; Pickar J; Constantine G
    Steroids; 2003 Nov; 68(10-13):921-6. PubMed ID: 14667984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of trimegestone alone or in combination with estradiol on bone mass and bone turnover in an adult rat model of osteopenia.
    Bouali Y; Gaillard-Kelly M; Marie PJ
    Gynecol Endocrinol; 2001 Feb; 15(1):48-55. PubMed ID: 11293924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical and clinical properties of trimegestone: a potent and selective progestin.
    Sitruk-Ware R; Bossemeyer R; Bouchard P
    Gynecol Endocrinol; 2007 Jun; 23(6):310-9. PubMed ID: 17616854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 1-year comparison of the efficacy and clinical tolerance in postmenopausal women of two hormone replacement therapies containing estradiol in combination with either norgestrel or trimegestone.
    Meuwissen JH; Beijers-De Bie L; Vihtamaki T; Tuimala R; Siseles N; Magaril C; The HS; Houben PW; Murga M; Spielmann D; De Villiers TJ
    Gynecol Endocrinol; 2001 Oct; 15(5):349-58. PubMed ID: 11727357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the metabolic tolerance in postmenopausal women over a 1-year period of two hormone replacement therapies containing estradiol in combination with either norgestrel or trimegestone.
    Meuwissen JH; Beijers-De Bie L; Vihtamaki T; Tuimala R; Siseles N; Magaril C; The HS; Houben PW; Murga M; Spielmann D; De Villiers TJ
    Gynecol Endocrinol; 2002 Apr; 16(2):155-62. PubMed ID: 12012627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
    Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The preclinical biology of a new potent and selective progestin: trimegestone.
    Winneker RC; Bitran D; Zhang Z
    Steroids; 2003 Nov; 68(10-13):915-20. PubMed ID: 14667983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors and activation markers of the haemostatic system during hormone therapy: a comparative study of oral estradiol (2 mg)/ dydrogesterone and estradiol (2 mg)/ trimegestone.
    Norris LA; Brosnan J; Bonnar J; Conard J; Kluft C; Hellgren M
    Thromb Haemost; 2008 Aug; 100(2):253-60. PubMed ID: 18690345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.